An Assessment of Statin Safety by Hepatologists

David E. Cohen, Frank A. Anania, Naga Chalasani

Research output: Contribution to journalArticle

283 Scopus citations

Abstract

The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

Original languageEnglish (US)
Pages (from-to)S77-S81
JournalAmerican Journal of Cardiology
Volume97
Issue number8 SUPPL. 1
DOIs
StatePublished - Apr 17 2006

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this